Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sureerat Padthaisong"'
Autor:
Raksawan Deenonpoe, Prakasit Sa-ngiamwibool, Sasithorn Watcharadetwittaya, Malinee Thanee, Kitti Intuyod, Thachanan Kongpan, Sureerat Padthaisong, Rungtiwa Nutalai, Yaovalux Chamgramol, Chawalit Pairojkul
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Cholangiocarcinoma (CCA) is highly endemic in the Northeast Thailand. Recently, chromosome aberrations provided new insights into pathogenesis of CCA. Therefore, chromosome aberration might be used as a prognostic factor and therapeutic plan
Externí odkaz:
https://doaj.org/article/aecb371f348a4fc49dc48a492231fdfe
Autor:
Sureerat Padthaisong, Jutarop Phetcharaburanin, Poramate Klanrit, Jia V. Li, Nisana Namwat, Narong Khuntikeo, Attapol Titapun, Apiwat Jarearnrat, Arporn Wangwiwatsin, Panupong Mahalapbutr, Watcharin Loilome
Publikováno v:
Cancer & Metabolism, Vol 9, Iss 1, Pp 1-15 (2021)
Abstract Background Cholangiocarcioma (CCA) treatment is challenging because most of the patients are diagnosed when the disease is advanced, and cancer recurrence is the main problem after treatment, leading to low survival rates. Therefore, our und
Externí odkaz:
https://doaj.org/article/a8d4f955246f425d9ac7f1819a16674b
Autor:
Yingpinyapat Kittirat, Manida Suksawat, Suyanee Thongchot, Sureerat Padthaisong, Jutarop Phetcharaburanin, Arporn Wangwiwatsin, Poramate Klanrit, Sakkarn Sangkhamanon, Attapol Titapun, Watcharin Loilome, Hideyuki Saya, Nisana Namwat
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cancer-associated fibroblasts (CAFs) are the dominant component of the tumor microenvironment (TME) that can be beneficial to the generation and progression of cancer cells leading to chemotherapeutic failure via several mechanisms. Nevertheless, the
Externí odkaz:
https://doaj.org/article/c2095a9c937440ce8c379cc33bde99c5
Autor:
Malinee Thanee, Sureerat Padthaisong, Manida Suksawat, Hasaya Dokduang, Jutarop Phetcharaburanin, Poramate Klanrit, Attapol Titapun, Nisana Namwat, Arporn Wangwiwatsin, Prakasit Sa-ngiamwibool, Narong Khuntikeo, Hideyuki Saya, Watcharin Loilome
Publikováno v:
Cancer & Metabolism, Vol 9, Iss 1, Pp 1-13 (2021)
Abstract Background Sulfasalazine (SSZ) is widely known as an xCT inhibitor suppressing CD44v9-expressed cancer stem-like cells (CSCs) being related to redox regulation. Cholangiocarcinoma (CCA) has a high recurrence rate and no effective chemotherap
Externí odkaz:
https://doaj.org/article/436d2befa68f4a3fbf390038f1d999f8
Autor:
Sureerat Padthaisong, Malinee Thanee, Nisana Namwat, Jutarop Phetcharaburanin, Poramate Klanrit, Narong Khuntikeo, Attapol Titapun, Sakkarn Sungkhamanon, Hideyuki Saya, Watcharin Loilome
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-17 (2020)
Abstract Background Cancer recurrence is the important problem of cholangiocarcinoma (CCA) patients, lead to a very high mortality rate. Therefore, the identification of candidate markers to predict CCA recurrence is needed in order to effectively ma
Externí odkaz:
https://doaj.org/article/d7e1e710e1884ad4a0f3a407485e22df
Autor:
Sureerat Padthaisong, Malinee Thanee, Nisana Namwat, Jutarop Phetcharaburanin, Poramate Klanrit, Narong Khuntikeo, Attapol Titapun, Watcharin Loilome
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-16 (2020)
Abstract Background Cancer recurrence is one of the most concerning clinical problems of cholangiocarcinoma (CCA) patients after treatment. However, an identification of predictive factor on Opisthorchis viverrini (OV)-associated CCA recurrence is no
Externí odkaz:
https://doaj.org/article/dd0f626efc78466c82d7fe69540b313d
Autor:
Jittima Tomacha, Hasaya Dokduang, Sureerat Padthaisong, Nisana Namwat, Poramate Klanrit, Jutarop Phetcharaburanin, Arporn Wangwiwatsin, Tueanjit Khampitak, Supinda Koonmee, Attapol Titapun, Apiwat Jarearnrat, Narong Khuntikeo, Watcharin Loilome
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
An aberrant regulation of lipid metabolism is involved in the pathogenesis and progression of cancer. Up-regulation of lipid biosynthesis enzymes, including acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN) and HMG-CoA reductase (HMGCR), has b
Externí odkaz:
https://doaj.org/article/1db805ff9f82404087a2165d8e14b02d
Publikováno v:
Expert Opinion on Investigational Drugs. 30:985-1006
Introduction Cholangiocarcinoma (CCA) is a malignant tumor of bile duct epithelium with the highest incidence found in Thailand. Some patients are considered suitable for adjuvant therapy and surgical resection is currently the curative treatment for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5198e89aa067addb9969a83ff232377b
https://doi.org/10.1080/13543784.2021.1955102
https://doi.org/10.1080/13543784.2021.1955102
Autor:
Tharatip Srisuk, Vasin Thanasukarn, David Park, Manida Suksawat, Anchalee Techasen, Watcharin Loilome, Bandit Thinkhamrop, Attapol Titapun, Prakasit Sa-Ngiamwibool, Narong Khuntikeo, Paiboon Sithithaworn, Alexa Dzienny, Apiwat Jareanrat, Simran Mahmud, Malinee Thanee, Ayse Caglayan, Vor Luvira, Sureerat Padthaisong, Kassaporn Duangkumpha
Publikováno v:
International Journal of General Medicine
Attapol Titapun,1,2 Vor Luvira,1,2 Tharatip Srisuk,1,2 Apiwat Jareanrat,1,2 Vasin Thanasukarn,1,2 Malinee Thanee,2,3 Prakasit Sa-Ngiamwibool,2,3 Sureerat Padthaisong,2,4 Kassaporn Duangkumpha,2,4 Manida Suksawat,2,4 Watcharin Loilome,2,4 Paiboon Sith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec446449a4d20194e993b77e0cf7c738
http://europepmc.org/articles/PMC8179826
http://europepmc.org/articles/PMC8179826
Autor:
Sakkarn Sangkhamanon, Poramate Klanrit, Wassana Jamnongkarn, Watcharin Loilome, Bundit Promraksa, Nisana Namwat, Hasaya Dokduang, Jutarop Phetcharaburanin, Manida Suksawat, Sureerat Padthaisong, Attapol Titapun, Malinee Thanee, Narong Khuntikeo
Publikováno v:
Drug Design, Development and Therapy. 14:2319-2334
Background Cholangiocarcinoma (CCA) is a slowly progressing but highly aggressive malignancy. Targeting the HER protein family represents a potential therapeutic strategy for CCA treatment. The pan-HER inhibitor varlitinib is being developed for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16bd490ef9ead607204eb8d1214baba2
https://doi.org/10.2147/dddt.s250061
https://doi.org/10.2147/dddt.s250061